Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Previous studies investigating the role of circulating microRNAs in acute coronary syndrome (ACS) were based on small patient numbers, performed no comparison with established markers of cardiac injury and did not have appropriate controls. We determined the potential diagnostic value of circulating microRNAs as novel early biomarkers in 332 suspected ACS patients on presentation to the emergency department (ED) in a prospective single-centre study including cardiac miRNAs (miR-1, -208a and -499), miR-21 and miR-146a. Levels of all miRs studied were significantly increased in 106 patients diagnosed with ACS, even in patients with initially negative high-sensitive (hs) troponin or symptom onset

Original languageEnglish
Pages (from-to)1176-1185
Number of pages10
JournalEmbo Molecular Medicine
Volume4
Issue number11
DOIs
Publication statusPublished - Nov 2012

Keywords

  • acute coronary syndrome
  • circulating microRNA
  • miR-1
  • miR-21
  • miR-499
  • ACUTE MYOCARDIAL-INFARCTION
  • CARDIOVASCULAR-DISEASE
  • PLASMA MICRORNA
  • HEART-FAILURE
  • BIOMARKERS
  • SERUM
  • TROPONIN
  • REVEALS
  • MARKERS
  • CANCER

Fingerprint

Dive into the research topics of 'Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs'. Together they form a unique fingerprint.

Cite this